Scholarlink

<p>Calcitonin-negative medullary thyroid cancer (CTNMTC) is a rare primary thyroid neuroendocrine carcinoma characterised by medullary thyroid carcinoma (MTC) morphology but without elevated serum calcitonin levels. However, the concurrent occurrence of CTNMTC and papillary thyroid carcinoma (PTC) is even rarer. We report a case of a 68-year-old male patient with normal serum calcitonin levels preoperatively, cytological and histopathological findings consistent with MTC morphology, and no detection of calcitonin by immunohistochemistry but positive reactions for thyroid transcription factor-1 (TTF-1) and synapsin (Syn). Additionally, histopathology indicated multifocal PTC. The diagnosis was calcitonin “double-negative” MTC combined with multifocal PTC, which, to our knowledge, is the first such case reported in the literature. It is prone to misdiagnosis due to its distinctive serologic and immunohistochemical manifestations. We also reviewed the relevant literature to provide a basis for the diagnosis and postoperative follow-up of such patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Calcitonin-negative medullary thyroid carcinoma combined with multifocal papillary thyroid carcinoma: a case report and literature review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月23日

查看全文
  • Wenjing Ma,
  • Lin Lin,
  • Wei Zhang,
  • Min Yang,
  • Dongsheng Zhou,
  • Zhen Jia,
  • Xiaolu Yang,
  • Ming Ci,
  • Jianning Wang,
  • Zhipeng Xu,
  • Dan Wei

摘要

Calcitonin-negative medullary thyroid cancer (CTNMTC) is a rare primary thyroid neuroendocrine carcinoma characterised by medullary thyroid carcinoma (MTC) morphology but without elevated serum calcitonin levels. However, the concurrent occurrence of CTNMTC and papillary thyroid carcinoma (PTC) is even rarer. We report a case of a 68-year-old male patient with normal serum calcitonin levels preoperatively, cytological and histopathological findings consistent with MTC morphology, and no detection of calcitonin by immunohistochemistry but positive reactions for thyroid transcription factor-1 (TTF-1) and synapsin (Syn). Additionally, histopathology indicated multifocal PTC. The diagnosis was calcitonin “double-negative” MTC combined with multifocal PTC, which, to our knowledge, is the first such case reported in the literature. It is prone to misdiagnosis due to its distinctive serologic and immunohistochemical manifestations. We also reviewed the relevant literature to provide a basis for the diagnosis and postoperative follow-up of such patients.